Regulatory support for medical device manufacturers navigating applicable Australian TGA requirements and market access pathways.
Quality system and audit-readiness support for medical device manufacturers working towards applicable MDSAP requirements.
Entering another regulated market brings new expectations around quality systems, product evidence, local responsibilities and ongoing compliance. DnA helps manufacturers understand what can be carried forward from their existing regulatory work and what needs to be adapted for MDSAP, Health Canada or TGA requirements.
Preparing an existing QMS for an upcoming MDSAP audit
Planning medical device entry into the Canadian market
Understanding manufacturer and sponsor requirements for Australia
Identifying country-specific gaps before beginning applications
Examine QMS processes and regulatory records against MDSAP expectations, highlighting areas that need attention before the audit.
Navigate Canadian device requirements with support for classification, quality system dependencies, licensing documentation and ongoing obligations.
Address classification, manufacturer evidence, conformity documentation and sponsor-related requirements for Australian market access.
Entering a second or third market should not mean rebuilding the regulatory file from zero. DnA reviews the evidence already available and separates reusable information from country-specific requirements, giving teams a clearer route into each intended market.
Map existing device, clinical, risk and quality evidence for reuse
Identify additional documentation required for Canada and Australia
Track market-specific changes, reporting and lifecycle obligations
One Device, Different Expectations:
The underlying product may be the same, but regulatory pathways are not. DnA helps manufacturers keep core evidence consistent while accounting for the requirements that differ between MDSAP, Health Canada and TGA pathways.
Core device and quality evidence may be reusable, but each market has its own regulatory expectations. DnA helps identify what can be carried forward and what needs market-specific adaptation.
DnA can review relevant QMS processes, regulatory records and country-specific requirements to identify areas requiring attention before MDSAP audit activities.
Support can cover applicable regulatory pathways, quality system interfaces, device documentation, manufacturer evidence and market-specific compliance requirements.
Make better use of established regulatory documentation while addressing the requirements that change across Canada, Australia and MDSAP jurisdictions.